Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statin therapy and angiogenesis.

Adriane Skaletz-Rorowski1, Kenneth Walsh

  • 1Institute for Arteriosclerosis Research and Department of Cardiology and Angiology, University of Münster, Münster, Germany.

Current Opinion in Lipidology
|November 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mosaic Loss-of-Y Chromosome in Men Is Associated With Aortic Enlargement But Not Aortic Stenosis.

JACC. Advances·2026
Same author

Transient efferocytosis-induced activation of IKKβ reprograms macrophages to promote tissue resolution.

bioRxiv : the preprint server for biology·2026
Same author

PCPE-1 promotes cardiac fibrosis with aging and obesity.

JCI insight·2026
Same author

Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoclast-like differentiation.

The Journal of clinical investigation·2026
Same author

Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

The Immunological Consequences of Clonal Hematopoiesis in Heart Failure.

Immunological reviews·2026
Same journal

Editorial introduction.

Current opinion in lipidology·2026
Same journal

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026
Same journal

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026
Same journal

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026
Same journal

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026
Same journal

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026
See all related articles

Statins exhibit dual effects on blood vessel growth, promoting it at low doses via Akt activation and nitric oxide, but inhibiting it at high doses. These lipid-independent cardiovascular benefits require further clinical investigation.

Area of Science:

  • Cardiovascular Pharmacology
  • Molecular Biology
  • Endothelial Cell Biology

Background:

  • Clinical studies indicate statin therapy offers cardiovascular protection beyond cholesterol reduction.
  • This protection may involve mechanisms independent of lipid-lowering effects.
  • Investigating these intracellular mechanisms is crucial for understanding statin's full therapeutic potential.

Purpose of the Study:

  • To review existing data on the cardiovascular protective activities of statins.
  • To discuss the potential intracellular mechanisms underlying these effects.
  • To explore the role of statins in angiogenesis and endothelial function.

Main Methods:

  • Review of experimental and clinical studies on statin effects.
  • Analysis of molecular mechanisms involving endothelial function and angiogenesis.

Related Experiment Videos

  • Examination of statin interactions with signaling pathways like Akt.

    • Main Results:

    • Statins protect against cardiac ischemia-reperfusion injury.
    • Statins promote angiogenesis in ischemic conditions via nitric oxide and Akt activation.
    • High statin doses may inhibit endothelial cell migration and angiogenesis.
    • These effects are observed in normocholesterolemic models, suggesting lipid-independent actions.

    Conclusions:

    • Statins demonstrate a biphasic effect on angiogenesis: promoting at low doses and inhibiting at high doses.
    • Low-dose statins enhance nitric oxide production and activate Akt, supporting angiogenesis.
    • High-dose statins may inhibit angiogenesis by affecting protein prenylation and cell growth.
    • The clinical significance of these lipid-independent effects remains to be fully elucidated.
    • Further research into statin actions on endothelial cells could reveal new therapeutic targets for angiogenesis control.